Cargando…
Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa: Advancements in computational therapeutics
The primary objective of this study is to uncover novel therapeutic agents for the treatment of Glioblastoma Multiforme (GBM), a highly aggressive form of brain cancer, and Alzheimer’s Disease (AD). Given the complexity and resistance associated with both conditions, the study underscores the impera...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635529/ https://www.ncbi.nlm.nih.gov/pubmed/37943817 http://dx.doi.org/10.1371/journal.pone.0293666 |
_version_ | 1785133016177180672 |
---|---|
author | Suhail, Mohd Tarique, Mohammad Tabrez, Shams Zughaibi, Torki A. Rehan, Mohd |
author_facet | Suhail, Mohd Tarique, Mohammad Tabrez, Shams Zughaibi, Torki A. Rehan, Mohd |
author_sort | Suhail, Mohd |
collection | PubMed |
description | The primary objective of this study is to uncover novel therapeutic agents for the treatment of Glioblastoma Multiforme (GBM), a highly aggressive form of brain cancer, and Alzheimer’s Disease (AD). Given the complexity and resistance associated with both conditions, the study underscores the imperative need for therapeutic alternatives that can traverse the biological intricacies inherent in both neuro-oncological and neurodegenerative disorders. To achieve this, a meticulous, target-based virtual screening was employed on an ensemble of 50 flavonoids and polyphenol derivatives primarily derived from plant sources. The screening focused predominantly on molecular targets pertinent to GBM but also evaluated the potential overlap with neural pathways involved in AD. The study utilized molecular docking and Molecular Dynamic (MD) simulation techniques to analyze the interaction of these compounds with a key biological target, protein tyrosine phosphatase receptor-type Z (PTPRZ). Out of the 50 compounds examined, 10 met our stringent criteria for binding affinity and specificity. Subsequently, the highest value of binding energy was observed for the synergistic binding of luteolin and ferulic acid with the value of -10.5 kcal/mol. Both compounds exhibited inherent neuroprotective properties and demonstrated significant potential as pathway inhibitors in GBM as well as molecular modulators in AD. Drawing upon advanced in-silico cytotoxicity predictions and sophisticated molecular modeling techniques, this study casts a spotlight on the therapeutic capabilities of polyphenols against GBM. Furthermore, our findings suggest that leveraging these compounds could catalyze a much-needed paradigm shift towards more integrative therapeutic approaches that span the breadth of both neuro-oncology and neurodegenerative diseases. The identification of cross-therapeutic potential in flavonoids and polyphenols could drastically broaden the scope of treatment modalities against both fatal diseases. |
format | Online Article Text |
id | pubmed-10635529 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-106355292023-11-10 Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa: Advancements in computational therapeutics Suhail, Mohd Tarique, Mohammad Tabrez, Shams Zughaibi, Torki A. Rehan, Mohd PLoS One Research Article The primary objective of this study is to uncover novel therapeutic agents for the treatment of Glioblastoma Multiforme (GBM), a highly aggressive form of brain cancer, and Alzheimer’s Disease (AD). Given the complexity and resistance associated with both conditions, the study underscores the imperative need for therapeutic alternatives that can traverse the biological intricacies inherent in both neuro-oncological and neurodegenerative disorders. To achieve this, a meticulous, target-based virtual screening was employed on an ensemble of 50 flavonoids and polyphenol derivatives primarily derived from plant sources. The screening focused predominantly on molecular targets pertinent to GBM but also evaluated the potential overlap with neural pathways involved in AD. The study utilized molecular docking and Molecular Dynamic (MD) simulation techniques to analyze the interaction of these compounds with a key biological target, protein tyrosine phosphatase receptor-type Z (PTPRZ). Out of the 50 compounds examined, 10 met our stringent criteria for binding affinity and specificity. Subsequently, the highest value of binding energy was observed for the synergistic binding of luteolin and ferulic acid with the value of -10.5 kcal/mol. Both compounds exhibited inherent neuroprotective properties and demonstrated significant potential as pathway inhibitors in GBM as well as molecular modulators in AD. Drawing upon advanced in-silico cytotoxicity predictions and sophisticated molecular modeling techniques, this study casts a spotlight on the therapeutic capabilities of polyphenols against GBM. Furthermore, our findings suggest that leveraging these compounds could catalyze a much-needed paradigm shift towards more integrative therapeutic approaches that span the breadth of both neuro-oncology and neurodegenerative diseases. The identification of cross-therapeutic potential in flavonoids and polyphenols could drastically broaden the scope of treatment modalities against both fatal diseases. Public Library of Science 2023-11-09 /pmc/articles/PMC10635529/ /pubmed/37943817 http://dx.doi.org/10.1371/journal.pone.0293666 Text en © 2023 Suhail et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Suhail, Mohd Tarique, Mohammad Tabrez, Shams Zughaibi, Torki A. Rehan, Mohd Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa: Advancements in computational therapeutics |
title | Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa: Advancements in computational therapeutics |
title_full | Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa: Advancements in computational therapeutics |
title_fullStr | Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa: Advancements in computational therapeutics |
title_full_unstemmed | Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa: Advancements in computational therapeutics |
title_short | Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa: Advancements in computational therapeutics |
title_sort | synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from angelica sinensis and cannabis sativa: advancements in computational therapeutics |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635529/ https://www.ncbi.nlm.nih.gov/pubmed/37943817 http://dx.doi.org/10.1371/journal.pone.0293666 |
work_keys_str_mv | AT suhailmohd synergisticinhibitionofglioblastomamultiformethroughaninsilicoanalysisofluteolinandferulicacidderivedfromangelicasinensisandcannabissativaadvancementsincomputationaltherapeutics AT tariquemohammad synergisticinhibitionofglioblastomamultiformethroughaninsilicoanalysisofluteolinandferulicacidderivedfromangelicasinensisandcannabissativaadvancementsincomputationaltherapeutics AT tabrezshams synergisticinhibitionofglioblastomamultiformethroughaninsilicoanalysisofluteolinandferulicacidderivedfromangelicasinensisandcannabissativaadvancementsincomputationaltherapeutics AT zughaibitorkia synergisticinhibitionofglioblastomamultiformethroughaninsilicoanalysisofluteolinandferulicacidderivedfromangelicasinensisandcannabissativaadvancementsincomputationaltherapeutics AT rehanmohd synergisticinhibitionofglioblastomamultiformethroughaninsilicoanalysisofluteolinandferulicacidderivedfromangelicasinensisandcannabissativaadvancementsincomputationaltherapeutics |